Navigation Links
Journal of Alzheimer's Disease once again achieves significant impact factor increase
Date:7/13/2009

Amsterdam, The Netherlands and San Antonio, TX, USA, July 13, 2009 International publisher IOS Press and the Editors-in-Chief of the Journal of Alzheimer's Disease (JAD) are pleased to announce that once again there has been a significant increase in the Journal's Impact Factor, from 4.081 to 5.101 for 2008 according to Thomson Reuters' Journal Citation Reports 2009. The Journal of Alzheimer's Disease continues to strengthen and build on its lead as the most prolific and highly cited journal in the Alzheimer's disease (AD) field. With an Impact Factor of over 5, JAD is now on par with or exceeds the ranking of some of the most established and highly regarded journals in the neurosciences, pathology and biochemistry.

Editors-in-Chief George Perry and Mark A. Smith commented, "As we celebrate JAD's 10th anniversary this year, it is extremely rewarding to see tangible evidence of the Journal's continually increasing value to AD researchers and academic physicians. Our primary goal is to promote the understanding of AD by building on the discoveries of the past, advancing research to identify preventive methods and improve treatment and working towards finding a cure. The dedication of the entire editorial board, contributing authors and our publisher, IOS Press, has been the key to the Journal's success."

"The Journal of Alzheimer's Disease is one of our flagship publications," stated Einar Fredriksson, Director of IOS Press. "It is extremely gratifying to see the impact that this journal is having in the field. As a specialist journal, it is particularly significant that it is ranked among the top journals included in JCR's Neurosciences category."


'/>"/>

Contact: Astrid Engelen
a.engelen@iospress.nl
31-206-883-355
IOS Press
Source:Eurekalert

0

GOOD

Page: 1

Related medicine news :

1. British Medical Journal Report Supports SCHS White Paper on Statins
2. Leading Nursing Web site, NurseZone.com Wins Award for Journalism Excellence
3. New impact factor of European Urology underlines journals outstanding position
4. SoundBite(TM) Hearing System by Sonitus Medical Receives First Acceptance for Publication in Otology & Neurotology Journal
5. Elsevier Announces 2008 Journal Impact Factor Highlights
6. Hospice of Michigan President and CEO Available for Comment on New England Journal of Medicine Article on Profits in Hospice Industry and Proposed Changes From MedPAC
7. Journal Publishes AssisTek Article on Best Practices in Electronic Patient Reported Outcomes (ePRO)
8. Michael E. DeBakey Journalism Award Recipients Announced
9. ANSi Answers When Awarded the Philadelphia Business Journals Prestigious 2009 South Jersey 25 Accolade
10. Springer to publish Journal of Medicine and the Person
11. DaVita Named to List of Best Places to Work in Los Angeles by the Los Angeles Business Journal

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... detailing plastic surgery procedures is now avail...ndidates can view procedures and print out informa... (PRWEB) December 2, 2009 -- Recov...ler, has always been dedicated to providing resour...dures, providing liposuction garments, breast augm...
(Date:12/2/2009)...g author James A. Feinstein, MD, has just released...sons from Patients on Becoming a Doctor, that trac... school--the grueling clinical year. , ..., 2009 -- Most people will, at some point or anoth...tal gown or staring at someone else dressed in a t...
(Date:12/2/2009)...wire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq:...fray Health Care Conference today at 2:30 p.m. Eas...cast live and may be accessed through a link on th....gen-probe.com . The webcast will be available for...be ,, Gen-Probe Incorporated is a global lead...
(Date:12/2/2009)...ewswire/ -- LeapFrog Investments has announced a Z...lLife, the innovative South African insurer servin...ent brings together LeapFrog, the leading microins...,s most innovative insurance businesses. The annou...lLife has developed a distinctive and profitable b...
(Date:12/2/2009)...inical trial presented today at the annual meeting...A) provide the first strong evidence of the benefi...nse breasts who are at elevated risk for breast ca... highly sensitive in depicting early breast cancer...und in addition to mammography significantly impro...
Breaking Medicine News(10 mins):Health News:Online Compression Garments Retailer Introduces 3D Animation of Surgical Procedures 2Health News:Beneath the Short White Coat: A Medical Student Reveals All 2Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 3Health News:Annual screening with breast ultrasound or MRI could benefit some women 2
...study by the Woolcock Institute of Medical Researc...tients with very mild or well-controlled asthma, r...icantly better dayto-day lung function. , The s...orticosteroids (ICS) and placebo on asthma control...
...iversity of Queensland researchers are leading the...is changing shape. , As the level of obesity in ...UQ School of Pharmacy,s Dr Bruce Green says resear...l sense, obesity presents a challenging role for c...
...ER, Mass., and BANBURY, Oxfordshire, March 10 IBA...reement with US-based,Sentillion to become its fir...ngle sign-on (SSO), context management, and user p...o offer its,customers the market-leading Vergence(...
...rances By Will Arnett, Matthew Broderick, Steve Ca...l, Tina Fey, Jonah Hill, Kevin James,Conan O,Brien...h Silverman, Triumph The Insult Comic Dog An...All Proceeds Going To A...
... Sessions to be Dedicated to the Prevention and Tr...lation to the Disease, CHICAGO, March 10 It has ...revent cervical cancer was approved for,regular cl... HPV and Cervical Cancer as well as the vaccine, i...
...ion Offers Better Patient Care and Reduced Costs f...ervice Delivery with Significant ROI, DETROIT, Ma...ay launched a new initiative to provide hospitals ...,delivery of health information systems, Compuware...
Other Medicine News:Health News:Treatment for mild asthma leads to improved lung function 2Health News:iSOFT Offers Healthcare Single Sign-On Solutions After Agreement with Sentillion 2Health News:iSOFT Offers Healthcare Single Sign-On Solutions After Agreement with Sentillion 3Health News:iSOFT Offers Healthcare Single Sign-On Solutions After Agreement with Sentillion 4Health News:COMEDY CENTRAL(R) Announces Live On-Air Charity Special 'Night Of Too Many Stars: An Overbooked Benefit For Autism Education' Hosted by Jon Stewart on Sunday April 13, at 8 p.m. ET 2Health News:COMEDY CENTRAL(R) Announces Live On-Air Charity Special 'Night Of Too Many Stars: An Overbooked Benefit For Autism Education' Hosted by Jon Stewart on Sunday April 13, at 8 p.m. ET 3Health News:Society of Gynecologic Oncologists 39th Annual Meeting on Women's Cancer to Include Sessions on HPV and Cervical Cancer 2Health News:Society of Gynecologic Oncologists 39th Annual Meeting on Women's Cancer to Include Sessions on HPV and Cervical Cancer 3Health News:Compuware Launches Strategic IT Service Management Initiative for Healthcare Industry 2Health News:Compuware Launches Strategic IT Service Management Initiative for Healthcare Industry 3
(Date:12/1/2009)..., VIENNA, Va., Dec. 1 CE... oncology company and a developer of vaccines and ...nfectious diseases, announced today that it has re...esearch Organization (CRO) to run CEL-SCI,s upcomi...ad and neck cancer with the Company,s lead product...
(Date:12/1/2009)..., MORRISVILLE, N.C., Dec. 1 nCo... investigation of devices for minimally-invasive t... initiation of a feasibility clinical trial design...ed surgical and catheter procedure, the convergent...ysmal atrial fibrillation (AF). This prospective,...
(Date:12/1/2009)..., MT. LAUREL, N.J., Dec. 1 /PRNewswire-FirstCall...vider of technology-enabled clinical documentation...ch tool from Primordial Design, Inc. has been inte...real-time speech recognition system. The solution ...of North America (RSNA) convention November 29 thr...
Breaking Medicine Technology:CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 2CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 3nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 2MedQuist Integrates Search Engine from Primordial with SpeechQ(TM) for Radiology 2Moores UCSD Cancer Center Luau 26 Longboard Invitational Celebrates 16 Years of Surfing for a Cure to Raise Funds for Cancer Research 52826 1Moores UCSD Cancer Center Luau 26 Longboard Invitational Celebrates 16 Years of Surfing for a Cure to Raise Funds for Cancer Research 52826 2Moores UCSD Cancer Center Luau 26 Longboard Invitational Celebrates 16 Years of Surfing for a Cure to Raise Funds for Cancer Research 52826 3Moores UCSD Cancer Center Luau 26 Longboard Invitational Celebrates 16 Years of Surfing for a Cure to Raise Funds for Cancer Research 52826 4Molecule plays early role in nonsmoking lung cancer 52821 1Molecule plays early role in nonsmoking lung cancer 52821 2121 breeding tigers estimated to be found in Nepal 9374 1121 breeding tigers estimated to be found in Nepal 9374 2
...euticals, Inc. (Nasdaq: ARNA ) announced today th...rial of APD125 in patients with primary,insomnia. ...na with the,potential to reduce insomnia symptoms ...hase 2b trial of APD125 is a double-blind, randomi...ng the efficacy and tolerability of,APD125 in pati...
...Navigenics, a,genetic health services company, tod... analysis. The Mayo Clinic study will examine how ...y a Navigenics genetic risk,assessment. The resear...etic assessments and the impact of such informatio...Proof of Principle Trial of Communication to,Patie...
Other Medicine Technology:Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 2Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 3Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 4Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 5Navigenics'(TM) Genome Analysis Used In Research Trial on the Impact of Providing Genetic Risk Assessments 2
...r beam is delivered through an ultra thin flexible... freedom of movement when performing surgery. The...of handpieces. Handpieces are supplied with stand...d angled fiber guides with different lengths offer...
Reusable Components
VersaStep™ Reposable (Reusable Components - Standard Length)
VersaStep™ Reposable Short Single-Use Instruments
Medicine Products: